| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |